Skip to main content

Symptomatic Cervical Disc Disease

1
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Zimmer Biomet
Zimmer BiometFL - Jacksonville
1 program
1
Anterior Cervical Discectomy and FusionPhase 31 trial
Active Trials
NCT00758758Completed231Est. Jun 2009
Globus Medical
Globus MedicalAUDUBON, PA
1 program
SECURE-C Cervical Artificial DiscN/A1 trial
Active Trials
NCT00882661Completed380Est. Feb 2017
Centinel Spine
Centinel SpinePA - West Chester
1 program
prodisc C SK and/or VivoN/A1 trial
Active Trials
NCT04012996Active Not Recruiting390Est. May 2028
Spine BioPharma
Spine BioPharmaNY - New York
1 program
prodisc C SK and/or VivoN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Zimmer BiometAnterior Cervical Discectomy and Fusion
Centinel Spineprodisc C SK and/or Vivo
Globus MedicalSECURE-C Cervical Artificial Disc

Clinical Trials (3)

Total enrollment: 1,001 patients across 3 trials

NCT00758758Zimmer BiometAnterior Cervical Discectomy and Fusion

Performance of the Hedrocel(R) Cervical Fusion Device

Start: Dec 2001Est. completion: Jun 2009231 patients
Phase 3Completed
NCT04012996Centinel Spineprodisc C SK and/or Vivo

2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C

Start: Aug 2019Est. completion: May 2028390 patients
N/AActive Not Recruiting
NCT00882661Globus MedicalSECURE-C Cervical Artificial Disc

SECURE®-C Cervical Artificial Disc Clinical Study/ SECURE-C Cervical Artificial Disc Postmarket Approval Study

Start: Jul 2005Est. completion: Feb 2017380 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.